Picture of HAMLET Pharma AB logo

HAMLET TO4 B HAMLET Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Hamlet Pharma Regains Patent Rights For BAMLET

Sept 4 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * HAMLET PHARMA REGAINS PATENT RIGHTS FOR BAMLET
    * BOARD OF HAMLET PHARMA HAS DECIDED TO ACCEPT A PROPOSAL
FROM
LINNANE PHARMA TO TERMINATE PATENT LICENSE AGREEMENT FROM MAY
12, 2020.
    * BOARD OF LINNANE PHARMA HAS THEREFORE PROPOSED THAT
LICENSING
AGREEMENT FROM 12 MAY BE TERMINATED
    * ALL RIGHTS HAVE BEEN RETURNED TO HAMLET PHARMA WITHOUT ANY
COMPENSATION TO LINNANE PHARMA

Source text for Eikon:  ID:nWkr9LRpJm 
Further company coverage:  HAMLET.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on HAMLET Pharma AB

See all news